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Abstract
Lipid accumulation in skeletal muscle results in dysregulation of protein meta-
bolism and muscle atrophy. We previously reported that treating C2C12 myo-
tubes with palmitate (PA), a saturated fatty acid, increases the overall rate of
proteolysis via activation of the ubiquitin-proteasome and autophagy systems;
co-treatment with the omega-3 polyunsaturated fatty acid docosahexaenoic
acid (DHA) prevents the PA-induced responses. Others have reported that PA
induces endoplasmic reticulum (ER) stress which initiates the unfolded pro-
tein response (UPR), a collective group of responses that can lead to activa-
tion of caspase-mediated proteolysis and autophagy. Presently, we tested the
hypothesis that DHA protects against PA-induced ER stress/UPR and its atro-
phy-related responses in muscle cells. C2C12 myotubes were treated with
500 lmol/L PA and/or 100 lmol/L DHA for 24 h. Proteins and mRNA asso-
ciated with ER stress/UPR, autophagy, and caspase-3 activation were evalu-
ated. PA robustly increased the phosphorylation of protein kinase R (PKR)-
like ER kinase (PERK) and eukaryotic initiation factor 2a (eIF2a). It also
increased the mRNAs encoding activating transcription factor 4 (ATF4),
spliced X-box binding protein 1 (XBP1s), C/EBP homologous protein
(CHOP), and autophagy-related 5 (Atg5) as well as the protein levels of the
PERK target nuclear factor erythroid 2-related factor (Nrf2), CHOP, and
cleaved (i.e., activated) caspase-3. Co-treatment with DHA prevented all of
the PA-induced responses. Our results indicate that DHA prevents PA-
induced muscle cell atrophy, in part, by preventing ER stress/UPR, a process
that leads to activation of caspase-mediated proteolysis and an increase in
expression of autophagy-related genes.
Introduction
Accumulation of saturated fatty acids (e.g., palmitate) in
skeletal muscle causes lipotoxic effects such as cell stress,
suppression of insulin signaling, and dysregulation of pro-
tein metabolism, all of which directly or indirectly con-
tribute to atrophy (Corcoran et al. 2007; Martins et al.
2012). Treatment of cultured myotubes with palmitate
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(PA) for 24–48 h results in a significant reduction in
myotube diameter, while co-treatment with the omega-3
polyunsaturated fatty acid docosahexaenoic acid (DHA)
prevents the response (Bryner et al. 2012). Recently, we
extended these observations by demonstrating that PA
increases the overall rate of protein degradation and that
DHA protects against the detrimental effects of PA, in
part, by restoring Akt-mediated inhibition of the FoxO3
transcription factor and subsequent expression of atrogin-
1 E3 ubiquitin ligase and components of the autophagy
pathway (i.e., Bnip3, LC3) (Woodworth-Hobbs et al.
2014).
A high-fat diet induces endoplasmic reticulum (ER)
stress in rodent skeletal muscle and PA has a similar effect
on cultured myotubes (Deldicque et al. 2010; Yuzefovych
et al. 2013). ER stress leads to activation of a series of
coordinated signaling networks called the unfolded pro-
tein response (UPR) that act as adaptive responses to re-
establish protein homeostasis (Lee and Ozcan 2014).
However, unresolved activation of the UPR can lead to
maladaptive responses including caspase-mediated prote-
olysis and increased expression of select autophagy pro-
teins. In the case of skeletal muscle, fatty acid-induced ER
stress may serve to provide components of the previously
noted proteolytic systems.
Three distinct branches of the UPR system can be initi-
ated by transmembrane effector signal transduction pro-
teins – protein kinase R (PKR)-like ER kinase (PERK),
inositol requiring enzyme 1 alpha (IRE1a), and activating
transcription factor 6 (ATF6). Early UPR events result in
inhibition of global protein synthesis, improved folding
capacity of nascent proteins in the ER through selective
transcription of a subset of genes, and removal of mis-
folded or unfolded proteins from the ER via a process
called ER-associated degradation (ERAD) (Dever 2002;
Ron and Walter 2007). One such early event, the activa-
tion of PERK, reduces the ER’s protein load by phospho-
rylating eukaryotic initiation factor 2a (eIF2a), reducing
the available eIF2•GTP•Met-tRNAi complex and suppress-
ing global protein synthesis (Harding et al. 1999;
Schr€oder and Kaufman 2005). Mutation of the PERK
gene impairs the ability of cells to survive ER stress due
to an inability to limit the synthesis of new proteins, sug-
gesting that PERK is required for the adaptive responses
to ER stress (Harding et al. 2000). In some cell types,
PERK activation has been linked to increases in mRNAs
that encode autophagy-related 12 (Atg12) and Atg5; both
proteins participate in autophagosome formation, an early
step in the autophagy process (Bernales et al. 2006; Ver-
faillie et al. 2010; Digaleh et al. 2013). Enhanced autop-
hagy facilitates the removal of damaged ER and insoluble
protein aggregates. Whether these responses occur in PA-
treated myotubes is unclear.
Failure to resolve prolonged or severe ER stress can
result in activation of caspase-3 which, in multi-nucleated
muscle cells, acts to degrade myofibrillar and other key
proteins involved in cell metabolism. Typically in most
cell types, the PERK/eIF2a pathway preferentially
enhances the expression of activating transcription factor
4 (ATF4) and there are several reports of increased ATF4
gene expression in muscle during diabetes and renal fail-
ure (Harding et al. 2000; Lecker et al. 2004; Sacheck et al.
2007). More recently, Ebert et al. (Ebert et al. 2010, 2015)
reported that ATF4 is a mediator of fasting-induced myo-
fiber atrophy and sarcopenia. A key effector gene target of
ATF4 is CCAAT-enhancer binding protein homologous
protein (CHOP), another transcription factor (Fawcett
et al. 1999; Harding et al. 2000).
Although ATF4 is required for CHOP expression,
CHOP is a downstream effector of all three branches of
the UPR (Oyadomari and Mori 2004). Enhanced CHOP
expression can have several effects on cells including alter-
ation of the balance of pro- and anti-apoptotic proteins
that act on mitochondria to control activation (i.e., cleav-
age) of caspase-3 (Oyadomari and Mori 2004). Caspase-3
activation is an important step in the progressive loss of
muscle protein due to chronic illness. Inhibition of cas-
pase-3 attenuates the proteolytic cleavage of actin during
diabetes and chronic kidney disease as well as disuse atro-
phy in the diaphragm (Du et al. 2004; McClung et al.
2007). Relevant to the present study, Peterson et al.
(2008) found that PA activates caspase-3 in myotubes.
When considered altogether, these findings led us to posit
that PA-initiated UPR stress may contribute to activation
of caspase-3 activation in muscle cells.
In this study, we investigated the effects of PA on ER
stress in myotubes by examining in detail several branches
of the ER stress/UPR system. In light of our recent find-
ings that DHA prevents the atrophy-inducing effects of
PA on protein degradation (Woodworth-Hobbs et al.
2014), we also tested the hypothesis that DHA reduces
the PA-induced activation of ER stress and UPR




Mouse C2C12 myoblasts (American Type Culture Collec-
tion, Manassas, VA) were grown in Dulbecco’s Modified
Eagle Medium (DMEM) containing 4.5 g/L glucose and
supplemented with 10% fetal bovine serum (FBS; Atlanta
Biologicals, Lawrenceville, GA) plus antibiotics (100 U/
mL penicillin, 100 lg/mL streptomycin; Invitrogen, Carls-
bad, CA). At 90–95% confluence, cells were induced to
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differentiate into myotubes in DMEM containing 4.5 g/L
glucose plus 2% horse serum (Invitrogen) and antibiotics
for 3–4 days before treatment with fatty acids.
Experimental treatments
Palmitate (PA) and cis-4, 7, 10, 13, 16, 19-docosahexae-
noic acid (DHA) (Sigma Aldrich, St. Louis, MO) were
dissolved in ethanol and added to DMEM containing 2%
bovine serum albumin (BSA; Roche, Indianapolis, IN),
2% FBS, 2 mmol/L L-carnitine (Sigma Aldrich), and 1%
antibiotics (treatment media) at final concentrations of
500 lmol/L and 100 lmol/L, respectively. When myo-
tubes were co-treated with PA and DHA, both fatty acids
were added to experimental media which was then added
to the cells. Others have reported that this combination
of fatty acids and BSA result in a final molar ratio that
approximates the levels in human plasma (Santomauro
et al. 1999). Control cells were incubated in treatment
media with equal amounts of ethanol substituted for PA
and DHA. Myotubes were incubated in experimental
media for 24 h. In some experiments, thapsigargin
(1 lmol/LolL) was added to myotubes for 17 h to
induce ER stress as described (Deldicque et al. 2011).
RNA isolation and qPCR analysis
RNA was isolated using TRIzol (Invitrogen) and reverse
transcribed using the Superscript III First-Strand Synthe-
sis kit (Invitrogen) according to the manufacturer’s
instructions. Specific mRNAs were measured by quantita-
tive real time PCR in a BioRad iCycler with iQ SYBR
Green reagent (BioRad Laboratories, Hercules, CA) and
previously published primer sets for ATF4 (Ebert et al.
2010), CHOP, XBP1s (Deldicque et al. 2011), Atg5 (Mar-
tinez et al. 2011), and Atg12 (De Palma et al. 2012). b-
actin was used as the qPCR normalization control. Data
were analyzed for fold change (DDCt) using the iCycler
software, as described (Zheng et al. 2010). Melting curve
analyses were performed to verify the specificity of the
reaction.
Western blot analysis
Whole cell lysates were prepared using the buffers speci-
fied by the antibody vendors. Protein concentrations of
cleared lysates were measured using a BioRad DC protein
assay (BioRad Laboratories, Hercules, CA). Western blot
analyses were performed as described (Gao et al. 2008)
using commercial antibodies to p-PERK (T980), PERK,
p-eIF2a(S51), eIF2a, CHOP, cleaved caspase-3 (Cell Sig-
naling Technology, Beverly, MA), and Nrf2 (Enzo Life
Sciences, Farmingdale, NY). Equal protein loading and
transfer to blot membranes was verified by Ponceau S
Red staining and quantification (Zheng et al. 2010). This
method avoids the confounding issues associated with
identifying “loading controls” that do not change when
the cell treatments being studied alter the synthesis and/
or degradation of most cellular proteins.
Statistical analyses
Data are presented as mean percentage of control  SE
of multiple experiments with 3–4 replicates per experi-
ment. Differences between treatments are compared by
one-way ANOVA with post hoc analysis by Tukey’s test
for multiple comparisons. For some western blots (i.e.,
cleaved caspase-3 and CHOP), bands were undetectable
in some lanes even after extensive exposures. In these
cases, the data were analyzed using the Freeman-Halton
extension of the Fisher’s exact probability test. Results are
considered statistically significant at P < 0.05. All analyses
were performed using GraphPad Prizm or InStat (La
Jolla, Ca).
Results
DHA attenuates the induction of ER stress
by PA
An essential response to ER stress is the PERK-mediated
decrease in global protein synthesis to reduce ER client
protein load. ER stress causes dissociation of PERK from
the protein chaperone BiP (Lee and Ozcan 2014); subse-
quent dimerization and trans-autophosphorylation of its
cytosolic domain stimulates its protein kinase activity
which can be measured as the phosphorylation of thre-
onine-980 (T980). In our experiments, treatment with PA
for 24 h increased phospho-PERK (T980) protein by over
fivefold (Fig. 1A and B) while total PERK protein was
reduced 44  11% (Fig. 1A and C). This resulted in a
9.8-fold increase in the phospho:total PERK ratio
(Fig. 1D). The suppression of global protein synthesis by
PERK depends on the deactivation of eIF2 via phosphory-
lation of the eIF2a subunit on serine-51. Accordingly, PA
increased phospho-eIF2a (S51) by ~5.4-fold (Fig. 2A and
B). Total eIF2a protein did not change with any fatty acid
treatment (Fig. 2A and C). Thus, the phospho:total eIF2a
ratio was increased by >5-fold in PA-treated myotubes
(Fig. 2D).
To determine if DHA could prevent PERK activation
and relieve the inhibition of eIF2a, myotubes were co-
treated with PA and DHA. DHA attenuated both the PA-
induced increase in PERK activation (Fig. 1A–D) and the
downstream phosphorylation of eIF2a (Fig. 2A–D). To
further confirm the effects of DHA on PA-induced PERK
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activation, we measured another relevant PERK target,
nuclear factor erythroid 2-related factor (Nrf2). The phos-
phorylation of Nrf2 by PERK stabilizes it, resulting in an
increase in Nrf2 protein (Digaleh et al. 2013). PA aug-
mented Nrf2, and notably, co-treatment with DHA pre-
vented the response (Fig. 2E).
DHA attenuates the ER stress-associated
caspase signaling induced by PA
If ER stress remains unresolved, the UPR transitions from
mediating adaptive survival responses to inducing
responses associated with autophagy and caspase-3 (Lee
and Ozcan 2014). Typically, these maladaptive responses
involve ATF4. In our studies, PA increased ATF4 mRNA
by over twofold and DHA prevented the response
(Fig. 3A). CHOP is a downstream target of ATF4 as well
as the other two arms of the UPR and its transcription is
induced in response to severe and/or prolonged ER stress
(Oyadomari and Mori 2004). After 24 h, PA robustly and
significantly increased the levels of CHOP mRNA
(Fig. 3B) and protein (Fig. 3C), while co-treatment with
DHA completely prevented the responses (Fig. 3B and
C). Since the basal level of CHOP is typically very low
under non-stressful conditions, it was not surprising that
CHOP protein was undetectable in the control or DHA-
treated cells, even after overexposing the films for an
extended period of time (Ron and Habener 1992). To test
whether the other two arms of the UPR upstream of
CHOP were also activated by PA, we measured the level
of mRNA encoding the spliced (i.e., active) form of X-
box binding protein 1 (XBP1s), another UPR-associated
transcription factor. It represents the integrated actions of
the ATF6 and IRE1a pathways; activated ATF6 increases
XBP1 transcription whereas the ribonuclease activity of
IRE1a produces XBP1s (Yoshida et al. 2001). PA signifi-
cantly increased XBP1s mRNA by almost threefold, and
importantly, co-treatment with DHA prevented the
increase (Fig. 3D).
Induction of CHOP signaling can result in several cel-
lular responses including activation of autophagy and cas-
pase-3 (Heath-Engel et al. 2008). In some cell types,
Figure 1. Co-treatment with DHA attenuates the PA-induced increase in PERK activation. (A) Representative western blots for phospho-PERK
(T980) and total PERK are shown. (B) PA increases phosphorylation of PERK (*P < 0.05 vs. control and DHA, n = 5 experiments) and (C)
decreases total PERK (*P < 0.01 vs. control, n = 5). (D) Co-treatment with DHA attenuates the PA-induced increase in the phospho:total PERK
ratio (*P < 0.001 vs. all other groups, n = 5). The dotted line across each graph is a reference line for 100% of the mean control value. Data
are presented as mean percentage of control  SE of multiple experiments.
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CHOP and/or its upstream mediator, ATF4, increase the
transcription of genes involved in autophagy (e.g., Atg5,
Atg12) (B’chir et al. 2013). Since expression of two
autophagy-related proteins, Bnip3 and LC3b, was
increased by PA in our earlier study (Woodworth-Hobbs
et al. 2014), we measured Atg5 and Atg12 mRNAs to
determine if PA also increases their levels in our experi-
mental model. Atg5 mRNA was increased 240% by PA
(P < 0.01) and was normalized by co-treatment with
DHA (Fig. 4A). Similarly, PA increased Atg12 mRNA
198% and DHA plus PA prevented the increase (Fig. 4B).
To test for caspase-3 activation, we evaluated protein
samples for the presence of cleaved (i.e., activated)
caspase-3. Like CHOP, cleaved caspase-3 is normally
absent or present at a low level in unstressed cells. As
expected, cleaved caspase-3 was undetectable in the con-
trol and DHA-treated samples, whereas PA induced a sig-
nificant increase in caspase-3 cleavage and co-treatment
with DHA attenuated the response (Fig. 4C).
Discussion
The ER is responsible for folding, processing, trafficking,
and quality control of many cellular proteins. In response
to cell stress, it can both suppress the general synthesis of
nascent proteins and augment the activity of several
Figure 2. Co-treatment with DHA attenuates PA-induced phosphorylation of eIF2a. (A) Representative western blots for phospho-eIF2a (S51)
and total eIF2a are shown. (B) PA increases the phosphorylation of eIF2a (P < 0.0001, n = 4 experiments) while (C) total eIF2a protein does not
change in response to treatment with the fatty acids (n = 4). (D) PA increases the ratio of phospho:total eIF2a protein (P < 0.0001, n = 4),
while PA + DHA co-treatment attenuated the change in phospho:total eIF2a protein (P < 0.0001, n = 4). (E) Co-treatment with DHA
antagonizes the PA-induced increase in Nrf2 protein (*P < 0.01 vs. all other groups, n = 3). A representative western blot is shown above the
graph. The dotted line across each graph is a reference line for 100% of the mean control value.
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proteolytic systems (e.g., ubiquitin-proteasome, autop-
hagy) that remove damaged proteins and organelles
(Heath-Engel et al. 2008; Lee and Ozcan 2014). Persistent
activation of ER stress induces UPR signals that can lead
to mitochondrial instability and activation of caspase-
mediated proteolysis and/or autophagy-related gene
expression (Ron and Walter 2007; Heath-Engel et al.
2008). All three of these proteolytic systems are well-
documented to be involved in the loss of muscle mass
during chronic illness (Price et al. 2010; Sandri 2013). We
recently reported that PA reduces the cross-sectional area
of C2C12 myotubes and increases their measured rate of
protein degradation, in part, by enhancing FoxO3 tran-
scription factor activity via reduced Akt activity (Bryner
et al. 2012; Woodworth-Hobbs et al. 2014). This results
in upregulation of the ubiquitin-proteasome system and
some components of the autophagy pathway. Impor-
tantly, co-treatment of DHA with PA fully restored Akt
signaling as well as the rate of protein degradation in
those studies. Our present results extend these earlier
findings by examining the effects of PA and DHA on
other key intracellular pathways and components of the
protein degradation process in skeletal muscle. Specifi-
cally, we demonstrate that DHA also prevents the induc-
tion of the caspase-3 protease and Atg5/Atg12 mRNAs by
PA (Fig. 5). To the best of our knowledge, our results are
the first to establish: 1) a link between atrophy-related
responses (i.e., proteolytic system mRNAs and proteins)
and PA-induced activation of multiple branches of the
UPR; and 2) a protective role of DHA on ER stress/UPR
and proteolysis-related responses in skeletal muscle.
Similar to Deldicque et al. (2010) who studied skeletal
muscles of mice fed a high-fat diet, treating myotubes
with PA for 24 h potently activates PERK, as indicated by
its increased phosphorylation. PERK activation typically
leads to the phosphorylation of Ser-51 in eIF2a which
Figure 3. Co-treatment with DHA antagonizes the PA-induced increase in UPR-associated mRNAs and proteins. PA increases (A) ATF4 mRNA
(*P < 0.0001 vs. all other groups, n = 4 experiments), (B) CHOP mRNA (*P < 0.0001 vs. all other groups, n = 4), (C) CHOP Protein (P < 0.05
vs. all other groups, n = 4; representative western blot shown) and (D) spliced Xbp1 (Xbp1s) mRNA (*P < 0.01 vs. all other groups, n = 4).
Some cells were treated with 1 lmol/L thapsigargin (Thap) for 17 h to induce ER stress (far left lane). Co-treatment with DHA prevents all of
these responses. The dotted line across each graph is a reference line for 100% of the mean control value.
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“reprograms” its function in the protein translation pro-
cess (Baird and Wek 2012). This change leads to a
decrease in the global rate of protein synthesis which
reduces ER client protein load while also preferentially
inducing translation of a subset of proteins involved in
the stress response. Consistent with the observed PERK
response, PA induces the phosphorylation of eIF2a and
increases the level of Nrf2, another target of PERK that is
stabilized by phosphorylation. Importantly, the increase
in phospho-PERK, phospho-eIF2a, and Nrf2 were all
reversed with DHA co-treatment, findings consistent with
the conclusion that DHA decreases PERK activation and
the inhibitory reprogramming of eIF2a.
In myotubes, ER-stress-related changes in components
of the UPR can result in mitochondrial instability and
activation of both caspase proteases and autophagy. In
several models of muscle atrophy, ATF4 appears to medi-
ate some of these responses (Harding et al. 2000). PERK/
eIF2a signaling enables the preferential increase in ATF4
protein by selectively enhancing both the transcription of
the ATF4 gene and subsequent translation of the ATF4
mRNA (Dey et al. 2010). Our result documenting a PA-
induced increase in ATF4 mRNA is consistent with this
earlier finding.
Although ATF4 is essential for the induction of CHOP
transcription, the CHOP promoter also contains binding
sites for ATF6 and XBP1s and all three transcription fac-
tors are required for maximal induction of CHOP
(Yoshida et al. 2001; Oyadomari and Mori 2004). Since
XBP1s mRNA represents an integrated readout of the
ATF6 and IRE1a pathways and PA robustly increases the
level of XBP1s mRNA as well as CHOP mRNA and pro-
tein, our data indicate that all three branches of the UPR
are activated by the fatty acid. Furthermore, DHA pre-
vents the activation of all three UPR arms.
The current results build on our earlier findings by
providing evidence that additional mechanisms (i.e., ER
stress/UPR) act to support the PA-augmentation of pro-
tein degradation (Woodworth-Hobbs et al. 2014). Since
Nrf2 increases the expression of several proteasome sub-
units, an increase in Nrf2 protein, such as that seen with
PA treatment, is an indicator of increased ERAD and
ubiquitin-proteasome system activities (Digaleh et al.
2013). PA also increases the levels of Atg5 and Atg12
mRNAs, consistent with the observed up-regulation of
other mRNA and proteins (i.e., Bnip3, LC3) involved in
autophagosome formation (Woodworth-Hobbs et al.
2014). In addition, Atg5 and Atg12 can also act in concert
with CHOP at the level of mitochondria to activate cas-
pase-3 and we found evidence consistent with this as well
(Yousefi et al. 2006; Heath-Engel et al. 2008; Rubinstein
Assaf et al. 2011; Wing et al. 2011). Importantly, activa-
tion of caspase-3 in multi-nucleated myotubes and
myofibrils typically does not result in classical apoptosis
(Borisov and Carlson 2000). Instead, caspase-3 con-
tributes to the regulation of muscle protein metabolism
in multiple ways. It facilitates the degradation of myofib-
rillar and other muscle proteins by producing fragments
that are degraded by the ubiquitin-proteasome system
(Du et al. 2004; Workeneh et al. 2006). It also enhances
proteasome activity through cleavage of several 19S sub-
units (Wang et al. 2010). In addition, caspase-3 may
Figure 4. ER stress augments autophagy-related mRNAs and activates caspase-3. PA increases Atg5 (A) and Atg12 (B) mRNAs, while co-
treatment with DHA prevents the responses (Atg5, *P < 0.01 vs. all other groups, n = 6 experiments; Atg12, P < 0.05 vs. control, n = 6). The
dotted line across each graph is a reference line for 100% of the mean control value. (C) Co-treatment with DHA (PA+DHA) antagonizes the
PA-induced increase in cleaved (activated) caspase-3 (P < 0.05 vs. all other groups, n = 4); no change between groups was detected in
procaspase-3 protein. Myotubes were treated with 1 lmol/L thapsigargin (Thap) for 17 h as a positive control for ER stress/activation of
caspase-3 (far left lane). A representative western blot is shown; the top and bottom panels were taken from the same blot after exposure to
film for different lengths of time with the bottom panel exposed for a longer time.
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reshape protein synthesis by altering the activities of sev-
eral protein translation factors through proteolytic cleav-
age (Marissen et al. 2000).
In a recent study, Bohnert et al. (2016) investigated for
the first time whether 4-phenylbutyrate (4-PBA), a chemi-
cal chaperone that attenuates ER stress, would reduce the
muscle atrophy induced by cancer (€Ozcan et al. 2006; Hu
et al. 2014). Curiously, they found that 4-PBA induced
atrophy responses when administered to mice or cultured
myotubes; it also exacerbated the wasting induced by
tumors in mice and the reduction in diameter of cultured
myotubes incubated in tumor-conditioned media. These
surprising effects of 4-PBA could reflect a response to sev-
ere, prolonged inhibition of all three arms of ER stress;
mice were treated for 18 days and myotubes were treated
for 24 h. 4-PBA also has been reported to inhibit effector
proteins like HDAC5, raising the possibility that the
observed responses represent effects unrelated to ER stress
Figure 5. ER stress and the caspase proteolytic system are important regulators of muscle protein homeostasis. PA induces unfolded protein
responses by activating all three arms of the ER stress system. These responses lead to activation of caspase-3, presumably by inducing the
intrinsic caspase-3 pathway, and by increasing the expression of genes involved in autophagy. DHA counteracts the effects of PA by reducing
ER stress, thus antagonizing the increase in UPR mRNAs and proteins and preventing caspase-3 cleavage. Signaling and effector mRNAs/
proteins investigated in this study are indicated in gray.
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(Hu et al. 2014). Moreover, these outcomes are in con-
trast to those of Ebert et al. (2015) who used small mole-
cule inhibitors of ATF4 to show its important role as a
mediator of age- and fasting-related atrophy. Nonetheless,
the role of ER stress in muscle atrophy is an area of
research that warrants more extensive examination to
understand these differences.
In summary, our study provides additional evidence
that the signaling pathways which coordinate protein
degradation and protein synthesis are complex, extensive,
and interconnected. Specifically, the process by which ele-
vated saturated fatty acids cause muscle loss is multi-
faceted and involves coordination of multiple signaling
pathways and proteolytic systems. Our current results
demonstrate that PA induces multiple branches of the
UPR in cultured myotubes. This leads to increased
expression of genes encoding components of the autop-
hagy system as well as activation of the caspase-3 prote-
olytic system. Both of these systems contribute to the
muscle loss that occurs in a variety of diseases, many of
which are linked to hyperlipidemia and insulin resistance
(e.g., type II diabetes, chronic kidney disease, and heart
failure) (Franch and Price 2005; Carrero et al. 2013).
Importantly, DHA provides protection against nearly all
of the atrophy-inducing effects of PA identified to date.
Although its mechanism(s) of action remains unclear, its
anti-proteolytic effects impact multiple signaling pathways
(e.g., Akt/FoxO, UPR). Such multi-faceted properties sug-
gest that nutritional supplements enriched in DHA could
be a useful therapy to attenuate muscle loss linked to
many wasting conditions. Indeed, omega-3 fatty acid sup-
plements (i.e., DHA, EPA) have been reported to provide
promising muscle-sparing effects against disease-asso-
ciated cachexia and sarcopenia (Ma et al. 2015; Pap-
palardo et al. 2015; Smith et al. 2015).
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